` ENZN (Enzon Pharmaceuticals Inc) vs S&P 500 Comparison - Alpha Spread

ENZN
vs
S&P 500

Over the past 12 months, ENZN has underperformed S&P 500, delivering a return of -30% compared to the S&P 500's +16% growth.

Stocks Performance
ENZN vs S&P 500

Loading
ENZN
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ENZN vs S&P 500

Loading
ENZN
S&P 500
Difference
www.alphaspread.com

Performance By Year
ENZN vs S&P 500

Loading
ENZN
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Enzon Pharmaceuticals Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Enzon Pharmaceuticals Inc
Glance View

Market Cap
5.2m USD
Industry
Biotechnology

Enzon Pharmaceuticals, Inc. is a biopharmaceutical company. The company is headquartered in Cranford, New Jersey and currently employs 0 full-time employees. The firm intends to become an acquisition platform. The firm utilizes its net operating loss carryforwards (NOLs) and improves stockholder value. The company manages its source of royalty revenues from existing licensing arrangements with other companies.

ENZN Intrinsic Value
0.01 USD
Overvaluation 80%
Intrinsic Value
Price
Back to Top